ProMab Biotechnologies, Inc.

ProMab Biotechnologies, Inc.

PI
Company Profile

ProMab Biotechnologies, Inc.

Richmond, United States of America

0Products
1People
0Events
0Locations

Overview

Company details and contact information.

About

About ProMab Biotechnologies, Inc. Founded in 2001., ProMab Biotechnologies develops and commercializes recombinant proteins, antibodies, and engineered cell lines through the integration of bioinformatics, molecular biology, protein expression, purification techniques, gene cloning, microbiology, and immunology, using novel high-throughput technologies. ProMab provides its proprietary proteins, engineered cell lines, and antibodies to deliver innovative research and diagnostic products, as well as services for the global biomedical research community through collaborations, partnerships, and joint ventures with other biotechnology and bio-reagent companies. ProMab is also one of the leading suppliers of bio-reagents in the twenty-first century and is committed to improving human health with a focus on the field of immunotherapy, specifically CAR-T/NK cell technologies. Utilizing nearly two decades of experience generating highly specific and potent monoclonal antibodies, our success in CAR-T/NK development led us to become the first CAR-T CRO in the world. After the emergence of COVID-19, ProMab’s comprehensive experience allowed us to explore mRNA related therapies and lipid nanoparticle formulation. We now offer a fully comprehensive mRNA-LNP platform to breach new beginnings in alternative gene delivery and broadens ProMab’s offerings to many different fields of research such as vaccine research and protein replacement therapies. About ProMab Biotechnologies, Inc. Founded in 2001., ProMab Biotechnologies develops and commercializes recombinant proteins, antibodies, and engineered immune and primary cell lines through the integration of novel technologies and decades of experience, including CAR-T/NK and mRNA-lipid nanoparticle technology. Founded in 2001., ProMab Biotechnologies develops and commercializes recombinant proteins, antibodies, and engineered immune and primary cell lines through the integration of novel technologies and decades of experience, including CAR-T/NK and mRNA-lipid nanoparticle technology.

Address
2600 Hilltop Drive Building B, Richmond, CA, Richmond CA 94806, United States of America

People

Contacts connected to this company.